Geode Capital Management’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History
Bought
Maintained
Sold
Other funds holding ECTE
Geode Capital Management's ECTE Position: Q3 2016 in Review
Geode Capital Management sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2016, closing a stake of 52,333 shares — an estimated $68K sold.
Geode Capital Management first reported a position in ECTE in Q2 2013 and held it in 13 quarters. The position peaked at $111K in Q1 2015. 2 funds tracked by Wall St. Rank hold ECTE as of Q3 2016.
- Geode Capital Management reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2016 after selling out during the quarter.
- Geode Capital Management sold 52,333 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2016, an estimated $68K.
- Geode Capital Management first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 13 quarters.
- Geode Capital Management's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $111K in Q1 2015.
- 2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2016.
Based on Geode Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.